Gene · 2646
Papers2,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The causal effects of remnant cholesterol on increased risk of cardiovascular diseases in East Asians. | BMC Med | 2025 | 40859268 | PubTator, text mining | PubMed |
| Early lipid genetics: identification of common and rare genetic variants for lipid traits in Indian adolescents. | J Hum Genet | 2025 | 40841581 | PubTator, text mining | PubMed |
| A genome-wide study on gene-nutrient interactions for hyperuricemia in a large Korean cohort (KoGES). | Sci Rep | 2025 | 40835619 | PubTator, text mining | PubMed |
| Impact of genetic variants linked to liver fat and liver volume on MRI-mapped body composition. | JHEP Rep | 2025 | 40823175 | PubTator, text mining | PubMed |
| Contribution of PNPLA3, GCKR, MBOAT7, NCAN, and TM6SF2 Genetic Variants to Hepatocellular Carcinoma Development in Mexican Patients. | Int J Mol Sci | 2025 | 40806538 | PubTator, text mining | PubMed |
| Glucokinase activators contribute to gastrointestinal disease risks through metabolic-immune interplay in the gut-liver axis: insights from a multi-omics study. | Acta Diabetol | 2025 | 40748365 | PubTator, text mining | PubMed |
| Identification of biomarkers between coronary artery disease and non-alcoholic steatohepatitis: a combination of bioinformatics and machine learning. | Front Genet | 2025 | 40747105 | PubTator, text mining | PubMed |
| Pathological Evolution and Internal Medicine Management of Nonalcoholic Fatty Liver Disease (NAFLD) in the Era of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). | Cureus | 2025 | 40734888 | PubTator, text mining | PubMed |
| Polymorphism's MBOAT7 as Risk and MTARC1 as Protection for Liver Fibrosis in MASLD. | Int J Mol Sci | 2025 | 40650184 | PubTator, text mining | PubMed |
| A genome-wide association study in 10,000 individuals links plasma N-glycome to liver disease and anti-inflammatory proteins. | Nat Commun | 2025 | 40593539 | PubTator, text mining | PubMed |
| Extrahepatic Events in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and the Impact of Genetics and Alcohol Intake. | Hepatol Res | 2025 | 40590763 | PubTator, text mining | PubMed |
| Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Alleles on Longitudinal Outcomes. | Aliment Pharmacol Ther | 2025 | 40580198 | PubTator, text mining | PubMed |
| Unraveling time-dependent genetic components underlying alcohol response. | Neuropsychopharmacology | 2025 | 40544219 | PubTator, text mining | PubMed |
| Integrating genetics and lifestyles for precision nutrition in hypertriglyceridemia: A UK Biobank and KoGES analysis. | J Clin Lipidol | 2025 | 40517091 | PubTator, text mining | PubMed |
| Polygenic Risk Score for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Narrative Review. | Int J Mol Sci | 2025 | 40507973 | PubTator, text mining | PubMed |
| Deep Learning Reveals Liver MRI Features Associated With PNPLA3 I148M in Steatotic Liver Disease. | Liver Int | 2025 | 40478199 | PubTator, text mining | PubMed |
| Uncovering novel metabolic and inflammatory pathways in gout using Mendelian randomization. | Postgrad Med J | 2025 | 40444573 | PubTator, text mining | PubMed |
| Genetic Analysis Reveals a Protective Effect of Sphingomyelin on Cholelithiasis. | Genes (Basel) | 2025 | 40428345 | PubTator, text mining | PubMed |
| The association between genetic polymorphisms in GCKR and gout: A systematic review and meta-analysis. | Medicine (Baltimore) | 2025 | 40419928 | PubTator, text mining | PubMed |
| Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis. | BMC Genomics | 2025 | 40375105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2646/papers?page=5